Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surface.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsHovingh, Elise S
van den Broek, Bryan
Rooijakkers, Suzan H M
MetadataShow full item record
TitleAcquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surface.
Published inPlos Pathog 2017, 13(7):e1006531
PubliekssamenvattingWhooping cough, or pertussis, is a contagious disease of the respiratory tract that is re-emerging worldwide despite high vaccination coverage. The causative agent of this disease is the Gram-negative Bordetella pertussis. Knowledge on complement evasion strategies of this pathogen is limited. However, this is of great importance for future vaccine development as it has become apparent that a novel pertussis vaccine is needed. Here, we unravel the effect of Virulence associated gene 8 (Vag8) of B. pertussis on the human complement system at the molecular level. We show that both recombinant and endogenously secreted Vag8 inhibit complement deposition on the bacterial surface at the level of C4b. We reveal that Vag8 binding to human C1-inhibitor (C1-inh) interferes with the binding of C1-inh to C1s, C1r and MASP-2, resulting in the release of active proteases that subsequently cleave C2 and C4 away from the bacterial surface. We demonstrate that the depletion of these complement components in the bacterial surrounding and subsequent decreased deposition on B. pertussis leads to less complement-mediated bacterial killing. Vag8 is the first protein described that specifically prevents C1s, C1r and MASP-2 binding to C1-inh and thereby mediates complement consumption away from the bacterial surface. Unravelling the mechanism of this unique complement evasion strategy of B. pertussis is one of the first steps towards understanding the interactions between the first line of defense complement and B. pertussis.
- Virulence Associated Gene 8 of <i>Bordetella pertussis</i> Enhances Contact System Activity by Inhibiting the Regulatory Function of Complement Regulator C1 Inhibitor.
- Authors: Hovingh ES, de Maat S, Cloherty APM, Johnson S, Pinelli E, Maas C, Jongerius I
- Issue date: 2018
- Bordetella pertussis isolates vary in their interactions with human complement components.
- Authors: Brookes C, Freire-Martin I, Cavell B, Alexander F, Taylor S, Persaud R, Fry N, Preston A, Diavatopoulos D, Gorringe A
- Issue date: 2018 May 9
- Complement evasion by Bordetella pertussis: implications for improving current vaccines.
- Authors: Jongerius I, Schuijt TJ, Mooi FR, Pinelli E
- Issue date: 2015 Apr
- Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor.
- Authors: Hovingh ES, Mariman R, Solans L, Hijdra D, Hamstra HJ, Jongerius I, van Gent M, Mooi F, Locht C, Pinelli E
- Issue date: 2018 Mar 21
- The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing.
- Authors: Ganguly T, Johnson JB, Kock ND, Parks GD, Deora R
- Issue date: 2014 Jul